Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENTX | Stock Option (right to buy) | Award | $0 | +33.4K | $0.00 | 33.4K | Sep 13, 2023 | Ordinary Shares, par value NIS 0.0000769 per share | 33.4K | $0.81 | Direct | F1 |
Id | Content |
---|---|
F1 | This grant of options was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on June 6, 2023, subject to approval by the Company's shareholders, which was obtained on September 13, 2023. The options vest ratably on an annual basis over a three-year period that commenced on June 6, 2023. |